Global Adoptive Cellular Immunotherapy Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

REPORT SUMMARY
TABLE OF CONTENTS

Adoptive Cellular Immunotherapy market report explains the definition, types, applications, major countries, and major players of the Adoptive Cellular Immunotherapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

The report contains qualitative and quantitative analysis of the entire industry.

The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

By Player:
- Cellular Biomedicine Group Inc
- Novartis AG
- Celularity Inc
- Kite Pharma Inc
- Amgen Inc
- bluebird bio Inc
- Daiichi Sankyo Co Ltd
- Fosun Pharmaceutical AG
- HRAIN Biotechnology Co Ltd
- Autolus Therapeutics Plc
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Bellicum Pharmaceuticals Inc
- Takara Bio Inc
- Juno Therapeutics Inc
- Guangzhou Anjie Biomedical Technology Co Ltd
- Hangzhou Converd Co Ltd
- CARsgen Therapeutics Ltd
- Celgene Corp
- Nanjing Legend Biotech Co Ltd
- Gilead Sciences Inc
- Sorrento Therapeutics Inc
- Hebei Senlang Biotechnology Inc Ltd
- Bristol-Myers Squibb Co
- Celyad SA
- Cell Medica Ltd
- NantKwest Inc
- Nkarta Inc
- Beijing Immunochina Medical Science & Technology Co Ltd
- Ono Pharmaceutical Co Ltd
By Type:
- TIL
- LAK
- CAR-T
- TCR-T
- CIK
- NK
- DC
- Other
By End-User:
- Hospital
- Cancer Hospital
- Centers for Disease Control and Prevention
- Rehabilitation Center
- Other
By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- Spain
- France
- Italy
- Denmark
- Finland
- Norway
- Sweden
- Poland
- Russia
- Turkey
Asia-Pacific
- China
- Japan
- India
- South Korea
- Pakistan
- Bangladesh
- Indonesia
- Thailand
- Singapore
- Malaysia
- Philippines
- Vietnam
- Others
South America
- Brazil
- Colombia
- Chile
- Argentina
- Venezuela
- Peru
- Puerto Rico
- Ecuador
- Others
GCC
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
Africa
- Nigeria
- South Africa
- Egypt
- Algeriat
- Others
Oceania
- Australia
- New Zealand
TABLE OF CONTENT
1. Global Adoptive Cellular Immunotherapy Executive Summary
- 1.1 Introduction
- 1.2 Market Panorama, 2022
2 Coronavirus Impact
- 2.1 Adoptive Cellular Immunotherapy Outlook to 2028- Original Forecasts
- 2.2 Adoptive Cellular Immunotherapy Outlook to 2028- COVID-19 Affected Forecasts
- 2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
- 3.1 Potential Market Drivers and Opportunities
- 3.2 New Challenges and Strategies
- 3.3 Short Term and Long Term Adoptive Cellular Immunotherapy Market Trends
4 Key Inferences
5 Market Overview
- 5.1 Current Market Scenario
- 5.2 Porter's Five Forces Analysis
6 Global Adoptive Cellular Immunotherapy Market- Recent Developments
- 6.1 Adoptive Cellular Immunotherapy Market News and Developments
- 6.2 Adoptive Cellular Immunotherapy Market Deals Landscape
7 Adoptive Cellular Immunotherapy Raw Materials and Cost Structure Analysis
- 7.1 Adoptive Cellular Immunotherapy Key Raw Materials
- 7.2 Adoptive Cellular Immunotherapy Price Trend of Key Raw Materials
- 7.3 Adoptive Cellular Immunotherapy Key Suppliers of Raw Materials
- 7.4 Adoptive Cellular Immunotherapy Market Concentration Rate of Raw Materials
- 7.5 Adoptive Cellular Immunotherapy Cost Structure Analysis
8 Global Adoptive Cellular Immunotherapy Import and Export Analysis (Top 10 Countries)
- 8.1 Global Adoptive Cellular Immunotherapy Import by Region (Top 10 Countries) (2017-2028)
- 8.2 Global Adoptive Cellular Immunotherapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2022
- 9.1 Global Adoptive Cellular Immunotherapy Consumption and Growth Rate by Type (2017-2022)
- 9.2 Global Adoptive Cellular Immunotherapy Consumption and Growth Rate by Application (2017-2022)
10 Region and Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook till 2022
- 10.1 Global Adoptive Cellular Immunotherapy Consumption (2017-2022)
- 10.2 North America Consumption Analysis
- 10.3 Europe Consumption Analysis
- 10.4 APAC Consumption Analysis
- 10.5 South America Consumption Analysis
- 10.6 GCC Consumption Analysis
- 10.7 Africa Consumption Analysis
- 10.8 Oceania Consumption Analysis
11 Global Adoptive Cellular Immunotherapy Competitive Analysis
- 11.1 Cellular Biomedicine Group Inc
- 11.2 Novartis AG
- 11.3 Celularity Inc
- 11.4 Kite Pharma Inc
- 11.5 Amgen Inc
- 11.6 bluebird bio Inc
- 11.7 Daiichi Sankyo Co Ltd
- 11.8 Fosun Pharmaceutical AG
- 11.9 HRAIN Biotechnology Co Ltd
- 11.10 Autolus Therapeutics Plc
- 11.11 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- 11.12 Bellicum Pharmaceuticals Inc
- 11.13 Takara Bio Inc
- 11.14 Juno Therapeutics Inc
- 11.15 Guangzhou Anjie Biomedical Technology Co Ltd
- 11.16 Hangzhou Converd Co Ltd
- 11.17 CARsgen Therapeutics Ltd
- 11.18 Celgene Corp
- 11.19 Nanjing Legend Biotech Co Ltd
- 11.20 Gilead Sciences Inc
- 11.21 Sorrento Therapeutics Inc
- 11.22 Hebei Senlang Biotechnology Inc Ltd
- 11.23 Bristol-Myers Squibb Co
- 11.24 Celyad SA
- 11.25 Cell Medica Ltd
- 11.26 NantKwest Inc
- 11.27 Nkarta Inc
- 11.28 Beijing Immunochina Medical Science & Technology Co Ltd
- 11.29 Ono Pharmaceutical Co Ltd
12 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2028
- 12.1 Global Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
- 12.2 Global Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
13 Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook to 2028
- 13.1 Global Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)
- 13.2 North America Consumption Analysis
- 13.3 Europe Consumption Analysis
- 13.4 APAC Consumption Analysis
- 13.5 South America Consumption Analysis
- 13.6 GCC Consumption Analysis
- 13.7 Africa Consumption Analysis
- 13.8 Oceania Consumption Analysis
14 Conclusions
The List of Tables and Figures
- Table Definition of Adoptive Cellular Immunotherapy
- Figure of Adoptive Cellular Immunotherapy Picture
- Table Global Adoptive Cellular Immunotherapy Import by Region (Top 10 Countries) (2017-2028)
- Table Global Adoptive Cellular Immunotherapy Export by Region (Top 10 Countries) (2017-2028)
- Figure Global TIL Consumption and Growth Rate (2017-2022)
- Figure Global LAK Consumption and Growth Rate (2017-2022)
- Figure Global CAR-T Consumption and Growth Rate (2017-2022)
- Figure Global TCR-T Consumption and Growth Rate (2017-2022)
- Figure Global CIK Consumption and Growth Rate (2017-2022)
- Figure Global NK Consumption and Growth Rate (2017-2022)
- Figure Global DC Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global Hospital Consumption and Growth Rate (2017-2022)
- Figure Global Cancer Hospital Consumption and Growth Rate (2017-2022)
- Figure Global Centers for Disease Control and Prevention Consumption and Growth Rate (2017-2022)
- Figure Global Rehabilitation Center Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Table North America Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure United States Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Canada Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Mexico Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table Europe Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure Germany Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure UK Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Spain Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Belgium Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure France Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Italy Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Denmark Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Finland Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Norway Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Sweden Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Poland Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Russia Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Turkey Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table APAC Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure China Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Japan Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure India Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure South Korea Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Pakistan Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Bangladesh Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Indonesia Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Thailand Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Singapore Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Malaysia Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Philippines Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Vietnam Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table South America Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure Brazil Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Colombia Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Chile Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Argentina Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Venezuela Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Peru Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Puerto Rico Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Ecuador Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table GCC Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure Bahrain Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Kuwait Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Oman Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Qatar Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Saudi Arabia Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure United Arab Emirates Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table Africa Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure Nigeria Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure South Africa Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Egypt Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure Algeria Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table Oceania Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)
- Figure Australia Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Figure New Zealand Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)
- Table Cellular Biomedicine Group Inc Company Details
- Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Novartis AG Company Details
- Table Novartis AG Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Novartis AG Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Novartis AG Adoptive Cellular Immunotherapy Product Portfolio
- Table Celularity Inc Company Details
- Table Celularity Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Celularity Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Celularity Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Kite Pharma Inc Company Details
- Table Kite Pharma Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Kite Pharma Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Kite Pharma Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Amgen Inc Company Details
- Table Amgen Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Amgen Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Amgen Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table bluebird bio Inc Company Details
- Table bluebird bio Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table bluebird bio Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table bluebird bio Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Daiichi Sankyo Co Ltd Company Details
- Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Fosun Pharmaceutical AG Company Details
- Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Portfolio
- Table HRAIN Biotechnology Co Ltd Company Details
- Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Autolus Therapeutics Plc Company Details
- Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Portfolio
- Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
- Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Bellicum Pharmaceuticals Inc Company Details
- Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Takara Bio Inc Company Details
- Table Takara Bio Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Takara Bio Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Takara Bio Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Juno Therapeutics Inc Company Details
- Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Guangzhou Anjie Biomedical Technology Co Ltd Company Details
- Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Hangzhou Converd Co Ltd Company Details
- Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table CARsgen Therapeutics Ltd Company Details
- Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Celgene Corp Company Details
- Table Celgene Corp Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Celgene Corp Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Celgene Corp Adoptive Cellular Immunotherapy Product Portfolio
- Table Nanjing Legend Biotech Co Ltd Company Details
- Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Gilead Sciences Inc Company Details
- Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Sorrento Therapeutics Inc Company Details
- Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Hebei Senlang Biotechnology Inc Ltd Company Details
- Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Bristol-Myers Squibb Co Company Details
- Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Portfolio
- Table Celyad SA Company Details
- Table Celyad SA Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Celyad SA Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Celyad SA Adoptive Cellular Immunotherapy Product Portfolio
- Table Cell Medica Ltd Company Details
- Table Cell Medica Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Cell Medica Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Cell Medica Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table NantKwest Inc Company Details
- Table NantKwest Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table NantKwest Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table NantKwest Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Nkarta Inc Company Details
- Table Nkarta Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Nkarta Inc Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Nkarta Inc Adoptive Cellular Immunotherapy Product Portfolio
- Table Beijing Immunochina Medical Science & Technology Co Ltd Company Details
- Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Table Ono Pharmaceutical Co Ltd Company Details
- Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
- Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Main Business and Markets Served
- Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Portfolio
- Figure Global TIL Consumption Forecast and Growth Rate (2022-2028)
- Figure Global LAK Consumption Forecast and Growth Rate (2022-2028)
- Figure Global CAR-T Consumption Forecast and Growth Rate (2022-2028)
- Figure Global TCR-T Consumption Forecast and Growth Rate (2022-2028)
- Figure Global CIK Consumption Forecast and Growth Rate (2022-2028)
- Figure Global NK Consumption Forecast and Growth Rate (2022-2028)
- Figure Global DC Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Centers for Disease Control and Prevention Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Rehabilitation Center Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Table North America Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure United States Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Canada Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Mexico Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Table Europe Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure Germany Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure UK Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Spain Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Belgium Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure France Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Italy Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Denmark Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Finland Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Norway Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Sweden Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Poland Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Russia Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Turkey Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Table APAC Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure China Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Japan Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure India Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure South Korea Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Pakistan Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Bangladesh Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Indonesia Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Thailand Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Singapore Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Malaysia Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Philippines Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Vietnam Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Table South America Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure Brazil Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Colombia Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Chile Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Argentina Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Venezuela Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Peru Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Puerto Rico Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Ecuador Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Table GCC Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure Bahrain Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Kuwait Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Oman Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Qatar Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Saudi Arabia Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure United Arab Emirates Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Table Africa Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure Nigeria Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure South Africa Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Egypt Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure Algeria Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Table Oceania Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)
- Figure Australia Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
- Figure New Zealand Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

Adoptive Cellular Immunotherapy Market Report

Global Adoptive Cellular Immunotherapy Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

1. Global Adoptive Cellular Immunotherapy Executive Summary

2 Coronavirus Impact

3 Strategic Analytics to Boost Productivity and Profitability

4 Key Inferences

5 Market Overview

6 Global Adoptive Cellular Immunotherapy Market- Recent Developments

7 Adoptive Cellular Immunotherapy Raw Materials and Cost Structure Analysis

8 Global Adoptive Cellular Immunotherapy Import and Export Analysis (Top 10 Countries)

9 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2022

10 Region and Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook till 2022

11 Global Adoptive Cellular Immunotherapy Competitive Analysis

12 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2028

13 Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook to 2028

14 Conclusions

The List of Tables and Figures

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US